|
HUE031567T2
(hu)
*
|
2007-03-23 |
2017-07-28 |
Wyeth Llc |
Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására
|
|
GB0818453D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
US11065323B2
(en)
*
|
2008-10-27 |
2021-07-20 |
Glaxosmithkline Biologicals Sa |
Purification method
|
|
US8795689B2
(en)
*
|
2008-12-18 |
2014-08-05 |
Wyeth Llc |
Method for controlling Streptococcus pneumoniae serotype 19A polysaccharide molecular weight
|
|
US20100160622A1
(en)
*
|
2008-12-18 |
2010-06-24 |
Wyeth Llc |
Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
|
|
KR101450958B1
(ko)
|
2009-04-30 |
2014-10-15 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
폐렴구균 백신 및 그의 용도
|
|
EP3238742A1
(en)
|
2009-06-22 |
2017-11-01 |
Wyeth LLC |
Immunogenic compositions of staphylococcus aureus antigens
|
|
BRPI1011753B8
(pt)
|
2009-06-22 |
2021-05-25 |
Wyeth Llc |
conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem
|
|
TW201136603A
(en)
*
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
|
WO2011145108A2
(en)
*
|
2010-05-15 |
2011-11-24 |
Serum Institute Of India Ltd. |
Purification of capsular polysaccharides
|
|
JP5944480B2
(ja)
*
|
2011-03-22 |
2016-07-05 |
セルム・インスティテュート・オブ・インディア・ピーブイティー．・リミテッド |
多糖を調製するための新規な方法
|
|
CN102660602B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
CN102660603B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
一种快速纯化细菌荚膜多糖的方法
|
|
CN102660601B
(zh)
*
|
2012-04-17 |
2015-10-28 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
US9650411B2
(en)
*
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
|
CN104781413B
(zh)
*
|
2012-09-07 |
2018-01-23 |
Sk化学公司 |
用于具有肺炎球菌血清型的荚膜多糖的生产方法
|
|
WO2014053612A1
(en)
|
2012-10-03 |
2014-04-10 |
Novartis Ag |
Immunogenic composition
|
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
|
SG11201508999UA
(en)
|
2013-07-12 |
2015-11-27 |
Emd Millipore Corp |
A method of determining virus removal from a sample containing a target protein using activated carbon
|
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
NZ759686A
(en)
|
2014-01-21 |
2023-07-28 |
Pfizer |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
HUE064837T2
(hu)
*
|
2014-01-21 |
2024-05-28 |
Pfizer |
Streptococcus pneumoniae kapszuláris poliszacharidok és azok konjugátumai
|
|
HK1223273A1
(zh)
|
2014-01-21 |
2017-07-28 |
辉瑞大药厂 |
肺炎链球菌荚膜多糖及其缀合物
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
KR102149760B1
(ko)
|
2015-01-15 |
2020-08-31 |
화이자 인코포레이티드 |
폐렴구균 백신에서 사용하기 위한 면역원성 조성물
|
|
WO2016178123A1
(en)
|
2015-05-04 |
2016-11-10 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
US20180223326A1
(en)
*
|
2015-06-18 |
2018-08-09 |
The Research Foundation For Microbial Diseases Of Osaka University |
Method For Measuring Complement-Dependent Bactericidal Function With Respect To Pneumococci
|
|
PE20180657A1
(es)
|
2015-07-21 |
2018-04-17 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos
|
|
CN105131139B
(zh)
*
|
2015-07-31 |
2018-02-13 |
兰州生物制品研究所有限责任公司 |
一种肺炎链球菌荚膜多糖的纯化方法
|
|
CA3005524C
(en)
|
2015-11-20 |
2023-10-10 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
JP7001687B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体－タンパク質コンジュゲート組成物
|
|
BR112019001995A2
(pt)
|
2016-08-05 |
2019-05-07 |
Sanofi Pasteur, Inc. |
composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
AU2017388891C1
(en)
|
2016-12-30 |
2025-04-17 |
Vaxcyte, Inc. |
Polypeptide-antigen conjugates with non-natural amino acids
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
WO2018144438A1
(en)
|
2017-01-31 |
2018-08-09 |
Merck Sharp & Dohme Corp. |
Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
|
|
EP4656208A2
(en)
|
2017-01-31 |
2025-12-03 |
Merck Sharp & Dohme LLC |
Methods for making polysaccharide-protein conjugates
|
|
MX2019009869A
(es)
|
2017-02-24 |
2019-10-02 |
Merck Sharp & Dohme |
Formulaciones de vacunas de conjugado de neumococos.
|
|
AU2018225099B2
(en)
|
2017-02-24 |
2024-08-22 |
Merck Sharp & Dohme Llc |
Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
AU2018280272C1
(en)
|
2017-06-10 |
2021-05-06 |
Inventprise, Inc. |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
|
JP7111799B2
(ja)
|
2017-07-05 |
2022-08-02 |
インベントプライズ リミテッド ライアビリティ カンパニー |
溶菌酵素、接線流濾過、及びマルチモードクロマトグラフィを用いたワクチン生産のための多糖精製
|
|
US10702596B2
(en)
|
2017-07-05 |
2020-07-07 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
WO2019050813A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
|
|
PL3678654T3
(pl)
|
2017-09-07 |
2024-12-16 |
Merck Sharp & Dohme Llc |
Polisacharydy pneumokokowe i ich zastosowanie w immunogennych koniugatach polisacharyd-białko nośnikowe
|
|
MX394767B
(es)
|
2017-09-07 |
2025-03-24 |
Merck Sharp & Dohme Llc |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
|
|
CN107936128B
(zh)
*
|
2017-11-22 |
2020-07-03 |
成都欧林生物科技股份有限公司 |
一种简便有效的细菌疫苗纯化方法
|
|
NZ765694A
(en)
|
2017-12-06 |
2024-03-22 |
Merck Sharp & Dohme Llc |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
IL276230B2
(en)
|
2018-02-05 |
2024-01-01 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
JP7288451B2
(ja)
|
2018-02-05 |
2023-06-07 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体－タンパク質複合体組成物
|
|
WO2019212842A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
CN112074293B
(zh)
|
2018-04-30 |
2025-07-11 |
默沙东有限责任公司 |
生产肺炎链球菌荚膜多糖载体蛋白缀合物的方法
|
|
EP3788143B1
(en)
|
2018-04-30 |
2023-06-28 |
Merck Sharp & Dohme LLC |
Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
|
|
EA202190168A1
(ru)
|
2018-07-04 |
2021-06-07 |
Ваксайт, Инк. |
Усовершенствования в иммуногенных конъюгатах
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
US12018134B2
(en)
*
|
2018-07-19 |
2024-06-25 |
Glaxosmithkline Biological Sa |
Processes for preparing dried polysaccharides
|
|
JP7585203B2
(ja)
|
2018-12-12 |
2024-11-18 |
ファイザー・インク |
免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
|
|
US11642406B2
(en)
|
2018-12-19 |
2023-05-09 |
Merck Sharp & Dohme Llc |
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
JP7239509B6
(ja)
*
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
US20220265803A1
(en)
|
2019-07-31 |
2022-08-25 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
US12473379B2
(en)
*
|
2019-09-06 |
2025-11-18 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
|
AU2021224078B2
(en)
|
2020-02-21 |
2024-01-18 |
Pfizer Inc. |
Purification of saccharides
|
|
CN116075517A
(zh)
*
|
2020-06-12 |
2023-05-05 |
巴斯夫欧洲公司 |
改进的发酵液的脱矿化与诸如寡糖的精细化学品的纯化
|
|
JP7630603B2
(ja)
|
2020-08-10 |
2025-02-17 |
インベントプライズ・インコーポレイテッド |
出現血清型２４ｆを含む多価肺炎球菌複合糖質ワクチン
|
|
AU2021332183B2
(en)
|
2020-08-26 |
2025-12-18 |
Pfizer Inc. |
Group B streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
GB202016165D0
(en)
|
2020-10-12 |
2020-11-25 |
Optivalent Ltd |
Vaccine
|
|
US20230383324A1
(en)
|
2020-10-22 |
2023-11-30 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
|
KR20230097160A
(ko)
|
2020-11-04 |
2023-06-30 |
화이자 인코포레이티드 |
폐렴구균 백신에 사용하기 위한 면역원성 조성물
|
|
WO2022101745A2
(en)
|
2020-11-10 |
2022-05-19 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
CA3218544A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against bacterial and betacoronavirus infections
|
|
WO2022249106A2
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CA3221075A1
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
GB2614916A
(en)
|
2022-01-25 |
2023-07-26 |
Optivalent Ltd |
Intradermal vaccine complement
|
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
CN120265317A
(zh)
|
2022-11-22 |
2025-07-04 |
辉瑞公司 |
包含经缀合的荚膜糖抗原的免疫原性组合物及其用途
|
|
JP2025541706A
(ja)
|
2022-12-01 |
2025-12-23 |
ファイザー・インク |
肺炎球菌コンジュゲートワクチン製剤
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN121038808A
(zh)
|
2023-03-30 |
2025-11-28 |
辉瑞公司 |
包含缀合的荚膜糖抗原的免疫原性组合物及其用途
|
|
WO2024214016A1
(en)
|
2023-04-14 |
2024-10-17 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
US20240390471A1
(en)
|
2023-05-18 |
2024-11-28 |
Merck Sharp & Dohme Llc |
Compounds and adjuvant formulations useful in pneumococcal vaccines
|
|
CN121263203A
(zh)
|
2023-05-19 |
2026-01-02 |
葛兰素史克生物有限公司 |
诱导对呼吸道合胞病毒和肺炎链球菌感染的免疫反应的方法
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025219908A2
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Media and fermentation methods for polysaccharide production in bacterial cell culture
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|
